Effect of rosiglitazone, a PPAR-γ ligand on haloperidol-induced catalepsy.
作者信息
Gupta Gaurav, Singh Ramandeep, David Sheba Rani, Verma Rohit Kumar
出版信息
CNS Neurosci Ther. 2013 Sep;19(9):724-5. doi: 10.1111/cns.12137. Epub 2013 Jun 21.
Abstract
摘要
相似文献
1
Effect of rosiglitazone, a PPAR-γ ligand on haloperidol-induced catalepsy.
CNS Neurosci Ther. 2013 Sep;19(9):724-5. doi: 10.1111/cns.12137. Epub 2013 Jun 21.
2
The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
Vascul Pharmacol. 2007 Jun;46(6):456-62. doi: 10.1016/j.vph.2007.01.007. Epub 2007 Feb 8.
3
A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5217-5226. doi: 10.1167/iovs.17-22203.
4
PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms.
Brain Res. 2008 Dec 9;1244:164-72. doi: 10.1016/j.brainres.2008.09.074. Epub 2008 Oct 9.
5
Brain PPAR-γ promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones.
Nat Med. 2011 May;17(5):618-22. doi: 10.1038/nm.2332. Epub 2011 May 1.
6
Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective.
Lipids Health Dis. 2013 Mar 25;12:41. doi: 10.1186/1476-511X-12-41.
7
INT131: a selective modulator of PPAR gamma.
J Mol Biol. 2009 Mar 13;386(5):1301-11. doi: 10.1016/j.jmb.2009.01.025.
8
Dual Outcomes of Rosiglitazone Treatment on Fatty Liver.
AAPS J. 2016 Jul;18(4):1023-31. doi: 10.1208/s12248-016-9919-9. Epub 2016 Apr 28.
9
Effect of Withania somnifera root extract on haloperidol-induced catalepsy in albino mice.
Phytother Res. 2008 Feb;22(2):243-6. doi: 10.1002/ptr.2299.
10
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation.
Eur J Pharmacol. 2004 Nov 28;505(1-3):195-203. doi: 10.1016/j.ejphar.2004.10.020.
引用本文的文献
1
Metformin and its Nanoformulations in Cancer Prevention and Therapy.
Curr Pharm Des. 2025 Apr 8. doi: 10.2174/0113816128367242250214052019.
2
PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice.
Res Sq. 2023 Mar 2:rs.3.rs-2614714. doi: 10.21203/rs.3.rs-2614714/v1.
本文引用的文献
1
Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.
Toxicol Lett. 2012 Sep 18;213(3):332-44. doi: 10.1016/j.toxlet.2012.07.016. Epub 2012 Jul 27.
2
Evaluation of toxicological and antioxidant potential of Nardostachys jatamansi in reversing haloperidol-induced catalepsy in rats.
Int J Gen Med. 2010 May 26;3:127-36. doi: 10.2147/ijgm.s9156.
3
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
Eur J Neurosci. 2009 Mar;29(5):954-63. doi: 10.1111/j.1460-9568.2009.06657.x. Epub 2009 Feb 24.
4
Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.
Nature. 1980 Apr 3;284(5755):472-3. doi: 10.1038/284472a0.
5
Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase.
Eur J Biochem. 1974 Sep 16;47(3):469-74. doi: 10.1111/j.1432-1033.1974.tb03714.x.
6
Review of the Folin phenol protein quantitation method of Lowry, Rosebrough, Farr and Randall.
Anal Biochem. 1979 Dec;100(2):201-20. doi: 10.1016/0003-2697(79)90222-7.
Zotero 插件